• Car t-cell image

    Immunotherapy Clinical Trial for Relapsed Leukemia

    Dana-Farber/Boston Children's is the first and only site in New England to offer a breakthrough immunotherapy clinical trial for children with relapsed or treatment-resistant acute lymphoblastic leukemia.
    David Williams, MD

    Unlocking the Secrets of Pediatric Cancers can Help Children and Adults

    Understanding cancers of young children could also hold the key to understanding a broad range of adult cancers, David Williams, MD, writes.

    Palliative Care Eases the Burden of Serious Illness

    Pediatric palliative care helps maximize quality of life for children with serious life-threatening or life-limiting illness.
    Gene Therapy Study

    Gene Therapy for “Bubble Boy” Disease Appears Effective, Safe

    A new form of gene therapy for boys with “bubble boy” disease appears to be effective and may avoid the late-developing leukemia seen in patients in pioneering gene therapy trials in Europe more than a decade ago.
    sickle cell blood cell

    Hope Grows for Patients with Sickle Cell Disease

    Advances in research and treatment mean longer life expectancy and better managed pain for people with sickle cell disease.
  • Ranked #1 for Cancer Care

    US News

    Rated the top pediatric
    cancer center by U.S. News & World Report

  • Innovative Treatments

    Gene Therapy Callout2 

    Through clinical trials and research, Dana-Farber/Boston Children's is at the forefront of innovative treatments, including gene therapy.

  • What Parents of Children with Cancer Should Know

    If your child has cancer, stay positive. With recent advances, the five-year survival rate is 84 percent for all childhood cancers combined, up from 61 percent in the mid-1970s.